Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present.

about

An update on the strategies used for the treatment of chronic hepatitis B in children.

P2860

Q38692198-B4DE64DA-2154-43DF-8331-76EBC4ECB65A

P2860

Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present.

Item

http://www.wikidata.org/entity/Q45340695

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Hepatitis B virus in children: ...... known unknowns still present.

@en

Hepatitis B virus in children: ...... known unknowns still present.

@nl

type

Item

label

Hepatitis B virus in children: ...... known unknowns still present.

@en

Hepatitis B virus in children: ...... known unknowns still present.

@nl

prefLabel

Hepatitis B virus in children: ...... known unknowns still present.

@en

Hepatitis B virus in children: ...... known unknowns still present.

@nl

P1476

Hepatitis B virus in children: ...... known unknowns still present.

@en

P2093

Nedim Hadžić

http://www.w3.org/2001/XMLSchema#string

Sanjay Bansal

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy.

Defective natural killer cell anti-viral capacity in paediatric HBV infection.

Chronic hepatitis B: A wave of new therapies on the horizon.

Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B.

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.

Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?

Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B.

Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.

P304

360-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/HEP.28154

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281679274

http://www.w3.org/2001/XMLSchema#string

P698

26361247

http://www.w3.org/2001/XMLSchema#string

Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present.

about

P2860

P2860

Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698